Invention Grant
- Patent Title: Composition and method for treatment of depression and psychosis in humans
-
Application No.: US15987932Application Date: 2018-05-24
-
Publication No.: US10583138B2Publication Date: 2020-03-10
- Inventor: Daniel C. Javitt
- Applicant: Glytech LLC
- Applicant Address: US NJ Ft. Lee
- Assignee: GLYTECH, LLC
- Current Assignee: GLYTECH, LLC
- Current Assignee Address: US NJ Ft. Lee
- Agency: JMB Davis Ben-David
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/138 ; A61K31/4525 ; A61K31/42 ; A61K31/55 ; A61K31/554 ; A61K31/06 ; A61K31/135 ; A61K31/431 ; A61K31/551 ; A61K31/519 ; A61K31/553 ; A61K31/381 ; A61K45/06
Abstract:
This application relates to combination compositions for use in treatment of depression, and which can alleviate the anxiogenic side effects of certain antidepressant and antipsychotic medications. Methods for treatment of depression and medicament side effects, particular anxiety, akathisia, and associated suicidality are also described herein.
Public/Granted literature
- US20180263976A1 COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS Public/Granted day:2018-09-20
Information query
IPC分类:
